Testing effectiveness (Phase 2)Looking for participantsNCT05787561
What this trial is testing
Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic Cancer
Who this might be right for
Mesonephric Gynecologic Cancer
Memorial Sloan Kettering Cancer Center 40